MR1 Antikörper (AA 201-300)
Kurzübersicht für MR1 Antikörper (AA 201-300) (ABIN561278)
Target
Alle MR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant MR1.
-
Sequenz
- TEPPLVRVNR KETFPGVTAL FCKAHGFYPP EIYMTWMKNG EEIVQEIDYG DILPSGDGTY QAWASIELDP QSSNLYSCHV EHCGVHMVLQ VPQESETIPL
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- MR1 (NP_001522, 201 a.a. ~ 300 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- MR1 (Major Histocompatibility Complex, Class I-Related (MR1))
-
Andere Bezeichnung
- MR1
-
Hintergrund
-
Full Gene Name: major histocompatibility complex, class I-related
Synonyms: HLALS -
Gen-ID
- 3140
-
NCBI Accession
- NM_001531
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-